Viewing StudyNCT06385873



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06385873
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-13
First Post: 2024-04-24

Brief Title: RC48 Combined With Adebrelimab Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization: The First Affiliated Hospital with Nanjing Medical University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-05-01
Start Date Type: ESTIMATED
Primary Completion Date: 2027-05-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-05-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-04-24
First Submit QC Date: April 24 2024
Study First Post Date: 2024-04-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-10
Last Update Post Date: 2024-05-13
Last Update Post Date Type: ACTUAL